Aural Analytics Partners with Medidata
Aural Analytics has partnered with Medidata to add its Speech Vitals product to the Medidata Sensor Cloud Network.
Aural Analytics and Medidata are collaborating to deploy Speech Vitals as a standard offering within Medidata';s Sensor Cloud to further the breadth of its offering to critical data streams for researchers to leverage in their studies. Speech measures have been shown to have clinical relevance across cognitive, motor, respiratory, and behavioral domains and, along with other digital sensors, offer additional ways to characterize treatment effect, phenotype participants, and gain understanding of the impact of disease in a real-world setting.
"Our industry-leading analytics automatically extract clinically relevant biomarkers that are meaningful, interpretable, and have a demonstrated correlation to traditional measures," said Judy Smythe, CEO of Aural Analytics, in a statement. "Speech provides a rich mine of data, and our partnership with Medidata will simplify the adoption of speech assessments in studies."
"Medidata's Sensor Cloud Network will include Aural Analytics' Speech Vitals technology, making it easier than ever to leverage the power of speech in clinical research," said Ben Schlatka, vice president of digital biomarker solutions at Medidata, in a statement. "Speech is an important data stream complementing existing Sensor Cloud biometrics, enabling deeper insights into our patients' journey."
The NIH grant will support Aural Analytics work with Speech Vitals to deliver clinical-grade speech analytics.
Aural's Speech Vitals technology will support Koneksa digital biomarker technology during clinical trials of pharmaceuticals.
Aural Analytics and Healint partner on integration of speech analytics into Healint's clinical trials and consumer applications.
A2E enables speech collection for decentralized clinical trials, remote patient monitoring, telemedicine, and consumer applications.